Augmentation of Sinecomitant Immunity in Mice by γ-(9H-Purine-6-yl)thiomethyl L-Glutamate (6-MPG), a Water-Soluble Derivative of 6-Mercaptopurine
スポンサーリンク
概要
- 論文の詳細を見る
Effects of the administration of γ-(9H-purine-6-yl)thiomethyl L-glutamate (6-MPG), a water-soluble derivative of 6-mercaptopurine, on concomitant and sinecomitant immunity against the implanted MethA tumor were studied in BALB/c mice. In the concomitant immunity experiments, mice were intradermally inoculated with 1×10^5MethA cells at the right inguinal region on day 0. In sinecomitant immunity experiments, mice were similarly inoculated on day -21,and the grown tumor was excised on day -11. Both the tumor-bearing and tumor-ectomized animals were re-inoculated with 3×10^6MethA cells intradermally at the left inguinal region on day 10. Administration of 6-MPG (100mg/kg, i.p.) on days 3 through 7 significantly inhibited growth of the re-inoculated tumor in both series of experiments. Cyclophosphamide, adriamycin, mitomycin C and cis-diamminedichloroplatinum (II) had no significant effect on the growth of the re-inoculated tumor in the tumor-ectomized mice. Spleen cells harvested from the 6-MPG-treated tumor-ectomized mice showed a strong tumor-neutralizing activity (Winn assay).
- 公益社団法人日本薬学会の論文
- 1998-01-15
著者
-
Naito K
Discovery Research Laboratory Tanabe Seiyaku Co.
-
Tsujihara K
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Kashida T
Research Laboratories Tanabe Seiyaku Co. Ltd.
-
Tsujihara Kenji
Research Laboratories Tanabe Seiyaku Co. Ltd.
-
KASHIDA Tatsuo
Research Laboratories, Tanabe Seiyaku Co., Ltd.,
-
NARASAKI Naoko
Research Laboratories, Tanabe Seiyaku Co., Ltd.,
-
TAKEYAMA Shigeyuki
Research Laboratories, Tanabe Seiyaku Co., Ltd.,
-
NAITO Kazuaki
Research Laboratories, Tanabe Seiyaku Co., Ltd.,
-
奈良崎 直子
Research Laboratories Tanabe Seiyaku Co. Ltd.
-
Takeyama Shigeyuki
Research Laboratories Tanabe Seiyaku Co. Ltd.
関連論文
- Difference in Inhibitory Effects of Dexamethasone and Cyclosporin A on Sephadex Bead-Induced Airway Hyperresponsiveness and Inflammation in Rats
- Augmentation of Tumor Immunity by 6-Mercaptopurine (6-MP) and Its Analogs in the Double Grafted Tumor System in Mice
- Water-Soluble Antitumor Agents. I. Synthesis and Biological Activity of 6-S-Aminoacyloxymethyl Mercaptopurine Derivatives
- Correlation between eosinophilia induced by CD4^+ T cells and bronchial hyper-responsiveness
- Difference among Angiotensin - Converting Enzyme Inhibitors in Potentiating Effects on Bradykinin - Induced Microvascular Leakage in Guinea Pig Airways
- Na^+-Glucose Cotransporter Inhibitors as Antidiabetic Agents. III. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Modified at the OH Groups of the Glucose Moiety
- Na^+-Glucose Cotransporter Inhibitors as Antidiabetic Agents. II. Synthesis and Structure-Activity Relationships of 4'-Dehydroxyphlorizin Derivatives
- A Novel Anti-Allergic Drug, Betotastine Besilate, Suppresses Interleukin-5 Production by Human Peripheral Blood Mononuclear Cells
- Augmentation of Tumor Immunity in Mice by Intralesional Injection of Vitamin A
- Augmentation of Sinecomitant Immunity in Mice by γ-(9H-Purine-6-yl)thiomethyl L-Glutamate (6-MPG), a Water-Soluble Derivative of 6-Mercaptopurine
- PHARMACOKINETIC STUDIES ON 1-(2-CHLOROETHYL)-3-ISOBUTYL-3-(β-MALTOSYL)-1-NITROSOUREA (TA-077). III. PHARMACOKINETICS OF A NEW NITROSOUREA ANTITUMOR AGENT TA-077 in HUMANS (A PHASE I STUDY)
- PHARMACOKINETIC STUDIES ON 1-(2-CHLOROETHYL)-3-ISOBUTYL-3-(β-MALTOSYL)-1-NITROSOUREA (TA-077). I. BLOOD AND TISSUE CONCENTRATIONS OF A NEW NITROSOUREA ANTITUMOR AGENT TA-077 AND ITS METABOLITE TA-G AFTER INTRAVENOUS INJECTION OF TA-077 IN VARIOUS EXPERIME
- Synthesis and Antitumor Activity of 9-Acyloxyellipticines
- Synthesis and Antitumor Activity of Quaternary Salts of 2-(2'-Oxoalkoxy)-9-hydroxyellipticines
- Synthesis and Biological Activity of O-Alkyl-3-N-aminoacyloxymethyl-5-fluoro-2'-deoxyuridine Derivatives
- PHARMACOKINETIC STUDIES ON 1-(2-CHLOROETHYL)-3-ISOBUTYL-3-(β-MALTOSYL)-1-NITROSOUREA (TA-077). II. HYDROLYSIS BY TISSUE HOMOGENATES AND DRUG UPTAKE BY TUMOR CELLS IN VITRO
- SYNTHESIS AND ANTITUMOR ACTIVITY OF A NEW CLASS OF NITROSOUREAS (TA-077,A NEW ANTITUMOR AGENT)